Solanezumab

From Self-sufficiency
Jump to: navigation, search
Solanezumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target Beta amyloid
Identifiers
CAS Number 955085-14-0
ATC code none
Chemical data
Formula C6396H9922N1712O1996S42
Molar mass 144.1 kDa[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Solanezumab (proposed INN) is a monoclonal antibody being investigated as a neuroprotector[1] for patients with Alzheimer's disease.[2][3]

References

  1. International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.
  2. ClinicalTrials.gov NCT00749216 Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease
  3. ClinicalTrials.gov NCT00905372 Effect of LY2062430 on the Progression of Alzheimer's Disease (EXPEDITION)